• Kyodo

  • SHARE

A Japanese team of physicians won approval Friday from an Osaka University panel for its plan to carry out the world’s first clinical study for treating heart failure with sheets of cardiac muscle cells created from so-called iPS cells.

Given the panel’s approval for the regenerative medicine project, Osaka University professor Yoshiki Sawa and his colleagues applied with the health ministry later in the day to carry out the clinical study.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW